KINGWOOD EMERGENCY HOSPITAL
1. Target Overview & Investment Thesis
KINGWOOD EMERGENCY HOSPITAL is a 6-bed suburban community hospital in nan, TX with $20.1M in net patient revenue and a 27.3% operating margin. The hospital serves a payer mix of 16.8% Medicare, 1.1% Medicaid, and 82.2% commercial.
Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 27.3% to 34.7% (+736bps).
| Net Revenue HCRIS | $20.1M |
| Current EBITDA COMPUTED | $5.5M |
| Operating Margin COMPUTED | 27.3% |
| Occupancy HCRIS | 16.9% |
| Revenue / Bed COMPUTED | $3.3M |
| Net-to-Gross HCRIS | 99.9% |
| Distress Probability ML | 58.8% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 27.3% places it above the state median. Among 8 size-comparable peers (3-12 beds), the median margin is -44.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (3-12), prioritizing same-state peers. 8 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| KINGWOOD EMERGENCY HOSPITAL (Target) | TX | 6 | $20.1M | 27.3% |
| HERITAGE PARK SURGICAL HOSPITA | TX | 12 | $52.5M | 19.2% |
| MEMORIAL HERMANN KINGWOOD | TX | 10 | $34.1M | 14.5% |
| ALTUS HOUSTON HOSPITAL LP | TX | 10 | $18.3M | -45.7% |
| LILLIAN M. HUDSPETH MEMORIAL H | TX | 10 | $9.4M | -42.3% |
| MCCAMEY COUNTY HOSPITAL DISTRI | TX | 11 | $8.0M | -50.0% |
| NORTH RUNNELS HOSPITAL DISTRIC | TX | 12 | $7.7M | -37.2% |
| ST LUKES HEALTH MEMORIAL SAN A | TX | 10 | $7.3M | -49.3% |
| CAPROCK HOSPITAL | TX | 10 | $2.0M | -50.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $422K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $402K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $398K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $245K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $13K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $5.5M |
| + RCM Uplift | +$1.5M |
| Pro Forma EBITDA | $7.0M |
| Current Margin | 27.3% |
| Pro Forma Margin | 34.7% |
| WC Released (1x) | $771K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $8.5M | $51.0M | 6.04x | 43.3% |
| Base (11x exit) | 10.0x | 11.0x | $8.5M | $58.9M | 6.97x | 47.4% |
| Bull Case | 9.0x | 11.0x | $7.6M | $66.5M | 8.74x | 54.3% |
| Bull (12x exit) | 9.0x | 12.0x | $7.6M | $74.8M | 9.83x | 58.0% |
| Bear Case | 11.0x | 10.0x | $9.3M | $40.9M | 4.40x | 34.5% |
| Bear (11x exit) | 11.0x | 11.0x | $9.3M | $48.0M | 5.16x | 38.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 16.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 58.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 8 hospitals with 3-12 beds
- Same-state prioritization (n=21)
- Comp margins: P25=-49.5% / P50=-44.0% / P75=-24.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.